Decline in TB incidence by 16% from 237 per hundred thousand population in 2015 to 199 in 2022
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
These clinical studies support the interchangeability of adalimumab-fkjp at low-concentration with high-concentration adalimumab and ustekinumab biosimilarity
Tremelimumab (Imjudo) in combination with Durvalumab (Imfinzi) is indicated for the treatment of patients with unresectable hepatocellular carcinoma
New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids
Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test to triage human papillomavirus (HPV)-positive cervical cancer screening test results
The raised capital enables Medix Biochemica to continue execution of inorganic growth initiatives
This license will enable Abbott to enhance access to this novel therapy to more patients across India
Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma
A multi-disciplinary team of senior physicians opted to use Zidebactam/Cefepime under compassionate use
ACOIN has recognized Dr. Budhrani's exceptional work in promoting community and clinical ophthalmology
Subscribe To Our Newsletter & Stay Updated